For example, while the combined analysis revealed an overall suppression of the estrogen response pathway in the primary tumor, the individual analyses showed that this pathway was specifically enriched in ER+ primary tumors (HCI005, HCI011, H5097) compared with the matched metastatic samples (Figure 2H). This evidence concerns the gene ESR1 and neoplasm.